GEMCITABINE AND S-1 COMBINATION THERAPY IN PATIENTS WITH ADVANCED STAGE OF PANCREATIC CANCER

被引：0
|
作者：
Ouchi, J. [1 ]
Hijioka, M. [1 ]
Harada, S. [1 ]
Maruyama, Y. [1 ]
Funakoshi, A. [1 ]
机构：
[1] Kyushu Natl Canc Ctr, Dept Gastroenterol, Fukuoka, Japan
来源：
PANCREAS | 2008年 / 37卷 / 04期
关键词：
D O I：
10.1097/01.MPA.0000335356.63524.1b
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：488 / 488
页数：1
相关论文
共 50 条
  • [31] Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer
    Sudo, Kentaro
    Yamaguchi, Taketo
    Nakamura, Kazuyoshi
    Denda, Tadamichi
    Hara, Taro
    Ishihara, Takeshi
    Yokosuka, Osamu
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (02) : 249 - 254
  • [32] Phase I study of gemcitabine, cisplatin, and S-1 combination therapy for patients with untreated advanced biliary tract cancer
    Moriwaki, Toshikazu
    Ishida, Hiroyasu
    Araki, Masahiro
    Endo, Shinji
    Yoshida, Shigemasa
    Kobayashi, Mariko
    Hamano, Yukako
    Sugaya, Akinori
    Shimoyamada, Masahiro
    Hasegawa, Naoyuki
    Imanishi, Mamiko
    Ito, Yuka
    Sato, Daiki
    Hyodo, Ichinosuke
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2015, 22 (09) : 669 - 674
  • [33] A phase II study of gemcitabine, erlotinib, and S-1 in patients with advanced pancreatic cancer.
    Han, Boram
    Kim, Hyeong Su
    Choi, Dae Ro
    Shim, Byoungyong
    Lee, Kyung Hee
    Kim, Jin Won
    Kim, Jung Han
    Kim, Jung Hoon
    Song, Hunho
    Park, Choong Kee
    Moon, Sung Hoon
    Kim, Jong Hyeok
    Jeon, Jang Yong
    Lee, Jung Woo
    Zang, Dae Young
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [34] Phase II trial of S-1 in combination with gemcitabine in chemo-naive patients with locally advanced or metastatic pancreatic cancer
    Lee, G.
    Kim, H.
    Kang, M.
    Kim, T.
    Kim, H.
    Kang, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [35] DENDRITIC CELL VACCINATION IN COMBINATION WITH OK432, GEMCITABINE AND/OR S-1 IN PATIENTS WITH ADVANCED PANCREATIC OR BILIARY TRACT CANCER
    Ogasawara, M.
    Ota, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 239 - 239
  • [36] Gemcitabine and S-1 Combination Chemotherapy in Patients with Advanced Biliary Tract Cancer: A Retrospective Study
    Mita, Kazuhito
    Ito, Hideto
    Fukumoto, Masato
    Murabayashi, Ryo
    Nabetani, Masashi
    Koizumi, Kazuya
    Hayashi, Takashi
    CASE REPORTS IN ONCOLOGY, 2010, 3 (03): : 498 - 504
  • [37] Survival prolongation by dendritic cell vaccination in combination with OK-432, gemcitabine and/or S-1 in patients with advanced pancreatic cancer
    Ogasawara, Masahiro
    Ota, Shuichi
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [38] A Phase 1 Study of Gemcitabine and S-1 Concurrent Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
    Matsumura, Yuji
    Suyama, Masafumi
    Sai, Jinkan
    Kubokawa, Yoshihiro
    Kamiya, Takayoshi
    Watanabe, Sumio
    PANCREAS, 2011, 40 (05) : 799 - 800
  • [39] The Role of Gemcitabine/S-1 in the Neoadjuvant Setting for Locally Advanced Pancreatic Cancer
    Kinoshita, S.
    Sho, M.
    Takahiro, A.
    Nomi, T.
    Yamato, I.
    Hokuto, D.
    Yasuda, S.
    Nakajima, Y.
    PANCREAS, 2012, 41 (07) : 1157 - 1157
  • [40] A feasibility study of gemcitabine, S-1 and leucovorin combination therapy (GSL) for advanced biliary tract cancer
    Takahara, Naminatsu
    Isayama, Hiroyuki
    Nakai, Yousuke
    Sasaki, Takashi
    Saito, Kei
    Sato, Tatsuya
    Hakuta, Ryunosuke
    Ishigaki, Kazunaga
    Saito, Tomotaka
    Hamada, Tsuyoshi
    Mizuno, Suguru
    Kogure, Hirofumi
    Tada, Minoru
    Koike, Kazuhiko
    JOURNAL OF CHEMOTHERAPY, 2019, 31 (05) : 284 - 289
12345